tirzepatide shortage ending Ends Mounjaro and Zepbound Are No

And the clinical evidence for cycling between them

Results Data from one phase 2 trial, five international phase 3 trials and one regional phase 3 trial in Japan, each with at least one MACE-4 event, were included in this meta-analysis (Supplementary Table 1)

A key open question is whether this brain tissue damage resolves in the longer term

+ Why theyre leading the way in 2026 GLP-1 medications are receptor agonists that mimic a hormone our bodies make after we eat: glucagon-like peptide-1 (GLP-1)

It is important for patients to report any unusual or concerning symptoms to their healthcare provider, as individual responses to medication can vary significantly